122 related articles for article (PubMed ID: 34637634)
1. Racial Differences in Planned Hysterectomy Procedure Route.
Su WK; Coleman CM; Bossick AS; Lee-Griffith M; Wegienka G
J Womens Health (Larchmt); 2022 Jan; 31(1):31-37. PubMed ID: 34637634
[No Abstract] [Full Text] [Related]
2. Social determinants of access to minimally invasive hysterectomy: reevaluating the relationship between race and route of hysterectomy for benign disease.
Price JT; Zimmerman LD; Koelper NC; Sammel MD; Lee S; Butts SF
Am J Obstet Gynecol; 2017 Nov; 217(5):572.e1-572.e10. PubMed ID: 28784416
[TBL] [Abstract][Full Text] [Related]
3. Associations between Race/Ethnicity, Uterine Fibroids, and Minimally Invasive Hysterectomy in the VA Healthcare System.
Callegari LS; Katon JG; Gray KE; Doll K; Pauk S; Lynch KE; Uchendu US; Zephyrin L; Gardella C
Womens Health Issues; 2019; 29(1):48-55. PubMed ID: 30293778
[TBL] [Abstract][Full Text] [Related]
4. Association of Race/Ethnicity with Surgical Route and Perioperative Outcomes of Hysterectomy for Leiomyomas.
Ko JS; Suh CH; Huang H; Zhuo H; Harmanli O; Zhang Y
J Minim Invasive Gynecol; 2021 Jul; 28(7):1403-1410.e2. PubMed ID: 33242598
[TBL] [Abstract][Full Text] [Related]
5. Uterine weight and complications after abdominal, laparoscopic, and vaginal hysterectomy.
Louie M; Strassle PD; Moulder JK; Dizon AM; Schiff LD; Carey ET
Am J Obstet Gynecol; 2018 Nov; 219(5):480.e1-480.e8. PubMed ID: 29959931
[TBL] [Abstract][Full Text] [Related]
6. Does Universal Insurance Mitigate Racial Differences in Minimally Invasive Hysterectomy?
Ranjit A; Sharma M; Romano A; Jiang W; Staat B; Koehlmoos T; Haider AH; Little SE; Witkop CT; Robinson JN; Cohen SL
J Minim Invasive Gynecol; 2017; 24(5):790-796. PubMed ID: 28351763
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Race and Ethnicity on Use of Minimally Invasive Surgery for Myomas.
Schneyer RJ; Greene NH; Wright KN; Truong MD; Molina AL; Tran K; Siedhoff MT
J Minim Invasive Gynecol; 2022 Nov; 29(11):1241-1247. PubMed ID: 35793780
[TBL] [Abstract][Full Text] [Related]
8. The impact of surgeon volume on perioperative adverse events in women undergoing minimally invasive hysterectomy for the large uterus.
Bretschneider CE; Frazzini Padilla P; Das D; Jelovsek JE; Unger CA
Am J Obstet Gynecol; 2018 Nov; 219(5):490.e1-490.e8. PubMed ID: 30222939
[TBL] [Abstract][Full Text] [Related]
9. Contributors to Racial Disparities in Minimally Invasive Hysterectomy in the US Department of Veterans Affairs.
Katon JG; Bossick AS; Doll KM; Fortney J; Gray KE; Hebert P; Lynch KE; Ma EW; Washington DL; Zephyrin L; Callegari LS
Med Care; 2019 Dec; 57(12):930-936. PubMed ID: 31730567
[TBL] [Abstract][Full Text] [Related]
10. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.
Multinu F; Casarin J; Hanson KT; Angioni S; Mariani A; Habermann EB; Laughlin-Tommaso SK
JAMA Surg; 2018 Jun; 153(6):e180141. PubMed ID: 29641835
[TBL] [Abstract][Full Text] [Related]
11. Socioeconomic and racial predictors of undergoing laparoscopic hysterectomy for selected benign diseases: analysis of 341487 hysterectomies.
Abenhaim HA; Azziz R; Hu J; Bartolucci A; Tulandi T
J Minim Invasive Gynecol; 2008; 15(1):11-5. PubMed ID: 18262137
[TBL] [Abstract][Full Text] [Related]
12. Patient and Hospital Characteristics Associated with Minimally Invasive Hysterectomy: Evidence from 143 Illinois Hospitals, 2016 to 2018.
Traylor J; Simon M; Tsai S; Feinglass J
J Minim Invasive Gynecol; 2020; 27(6):1337-1343. PubMed ID: 32126301
[TBL] [Abstract][Full Text] [Related]
13. Association Between Body Mass Index, Uterine Size, and Operative Morbidity in Women Undergoing Minimally Invasive Hysterectomy.
Shah DK; Van Voorhis BJ; Vitonis AF; Missmer SA
J Minim Invasive Gynecol; 2016; 23(7):1113-1122. PubMed ID: 27523922
[TBL] [Abstract][Full Text] [Related]
14. Trends in operative time and outcomes in minimally invasive hysterectomy from 2008 to 2018.
Luchristt D; Brown O; Kenton K; Bretschneider CE
Am J Obstet Gynecol; 2021 Feb; 224(2):202.e1-202.e12. PubMed ID: 32791126
[TBL] [Abstract][Full Text] [Related]
15. Trends in the national distribution of laparoscopic hysterectomies from 2003 to 2010.
Lee J; Jennings K; Borahay MA; Rodriguez AM; Kilic GS; Snyder RR; Patel PR
J Minim Invasive Gynecol; 2014; 21(4):656-61. PubMed ID: 24462854
[TBL] [Abstract][Full Text] [Related]
16. Nationwide use of laparoscopic hysterectomy compared with abdominal and vaginal approaches.
Jacoby VL; Autry A; Jacobson G; Domush R; Nakagawa S; Jacoby A
Obstet Gynecol; 2009 Nov; 114(5):1041-1048. PubMed ID: 20168105
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) Centers.
Bergstrom J; Aloisi A; Armbruster S; Yen TT; Casarin J; Leitao MM; Tanner EJ; Matsuno R; Machado KK; Dowdy SC; Soliman PT; Wethington SL; Stone RL; Levinson KL; Fader AN
Gynecol Oncol; 2018 Mar; 148(3):480-484. PubMed ID: 29338923
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of prophylactic salpingectomy during vaginal hysterectomy.
Antosh DD; High R; Brown HW; Oliphant SS; Abed H; Philip N; Grimes CL
Am J Obstet Gynecol; 2017 Nov; 217(5):605.e1-605.e5. PubMed ID: 28734829
[TBL] [Abstract][Full Text] [Related]
19. Updated hysterectomy surveillance and factors associated with minimally invasive hysterectomy.
Cohen SL; Vitonis AF; Einarsson JI
JSLS; 2014; 18(3):. PubMed ID: 25392662
[TBL] [Abstract][Full Text] [Related]
20. Surgical Indication and Approach are Associated with Transfusion in Hysterectomy for Benign Disease.
Elfazari T; Nayak AL; Mallick R; Arendas K; Choudhry AJ; Chen I
JSLS; 2022; 26(2):. PubMed ID: 35655468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
